Beam Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Beam Therapeutics last closed at $25.70 (+4.47%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -30.0×. Its overall grade ranks 312 of 738 stocks in Healthcare.
About this company
Beam Therapeutics last closed at $25.70 (+4.47%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 312/738
Valuation grade A-
Related stocks
- Verve TherapeuticsCompetitor
유전자 편집 기반 심혈관 치료제 개발 경쟁사
- Intellia TherapeuticsCompetitor
유전자 편집 치료제 분야의 대표 경쟁사
- Editas MedicineCompetitor
CRISPR 기반 유전자 편집 치료제 경쟁사
About Beam Therapeutics
- What technical signals does Beam Therapeutics (BEAM) have?
- Beam Therapeutics current technical signals: no active technical signal.
- Is Beam Therapeutics a cup-and-handle pattern?
- No. Beam Therapeutics has no valid Cup signal right now.
- What published figures are available for Beam Therapeutics?
- Market cap: $2.61B. Trailing 12 months PER: -30.0×. Latest quarter PBR: 2.40×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Beam Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.